BPG致力于知识的发现和传播
在F6Publishing中引用其的文章
For: 杨林辉, 郭华, 蔡俊, 蔡晓伟, 刘贵伦, 陈东风. 枯草杆菌肠球菌二联活菌胶囊对非酒精性脂肪性肝炎肠道菌群失调的干预作用. 世界华人消化杂志 2012; 20(20): 1873-1878 [DOI: 10.11569/wcjd.v20.i20.1873]
URL: https://www.wjgnet.com/1009-3079/full/v20/i20/1873.htm
编号 Citing Articles
1
Xiaolin Gao, Yu Zhu, Yang Wen, Guanjian Liu, Chaomin Wan. Efficacy of probiotics in non‐alcoholic fatty liver disease in adult and children: A meta‐analysis of randomized controlled trialsHepatology Research 2016; 46(12): 1226 doi: 10.1111/hepr.12671
2
Meng-Wei Xiao, Shi-Xin Lin, Zhao-Hua Shen, Wei-Wei Luo, Xiao-Yan Wang. Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver DiseaseGastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/1484598
3
Zeinab Ghorbani, Nargeskhatoon Shoaibinobarian, Morvarid Noormohammadi, Kate Taylor, Asma Kazemi, Ali Bonyad, Sara Khoshdooz, Ulrike Löber, Sofia K. Forslund-Startceva. Reinforcing gut integrity: A systematic review and meta-analysis of clinical trials assessing probiotics, synbiotics, and prebiotics on intestinal permeability markersPharmacological Research 2025; 216: 107780 doi: 10.1016/j.phrs.2025.107780
4
Yutong Wu, Hao Wu, Hang Yi. Efficacy of interventions with live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules in metabolic associated fatty liver disease patients: a meta-analysis of randomized controlled trialsFrontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1610426
5
Xiongfeng Pan, Shi Wu Wen, Atipatsa C. Kaminga, Aizhong Liu. Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65051-8
6
Alicia Rodríguez-Pastén, Eduardo Fernández-Martínez, Nury Pérez-Hernández, Luis E. Soria-Jasso, Raquel Cariño-Cortés. Prebiotics and Probiotics: Effects on Dyslipidemia and NAFLD/NASH and the Associated Mechanisms of ActionCurrent Pharmaceutical Biotechnology 2023; 24(5): 633 doi: 10.2174/1389201023666220818145350